Glucotrack Announces Reverse Stock Split
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
01:01:32 PM UTC
SquawkNews
Glucotrack, Inc. (NASDAQ:GCTK) (“Glucotrack” or the “Company”), a healthcare technology and biopharmaceutical company operating Lōkahi Therapeutics™, today announced that it will effect a 1-for-2 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock, par value…
01:02:21 PM UTC
SquawkNews
Glucotrack will effect a 1-for-2 reverse stock split effective at the open on Oct. 26, 2026, aiming to meet Nasdaq’s $1.00 bid requirement under a Panel exception running through Nov. 9, 2026.Material DetailsContext by AI AnalystThis is a late-stage move to address persistent sub-$1 pricing after a…